🔹 @IBCG_BladderCA IR stratification → now in @NCCN guidelines
🔹 Our new @BJUIjournal study supports & simplifies it
🔹 3 factors → low / intermediate / high risk IR NMIBC
Easy to use in a busy clinic. No loss in accuracy. A practical tool for real🌎 #BladderCancer @Cl@ClevelandClinic@CCLRI@CleClinicUro as always free access >> https://t.co/89IUx86xnw